产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
名称 | RL95-2 (人子宫内膜癌细胞) (STR鉴定正确) |
别称 | RL-95-2; RL-952; RL952; RL95 |
背景描述 | RL95-2细胞有α角蛋白,定义明确的连接复合体,张力丝和表面微绒毛。 |
种属 | 人 |
年龄(性别) | 女;65岁 |
组织来源 | 器官:子宫;组织:内膜;疾病:癌 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 子宫内膜癌 |
生物安全等级 | 1 |
生长培养基 | DMEM/F12+5μg/ml Insulin+10% FBS+1% P/S |
推荐传代比例 | 1:2-1:3 |
推荐换液频率 | 2~3次/周 |
倍增时间 | ~22 hours |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养条件 | 气相:空气,95%;CO2,5% 温度:37℃ |
受体表达情况 | estrogen receptor, positive |
保藏机构 | ATCC; CRL-1671 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 10,11 D2S1338 22,23 D3S1358 14,16 D5S818 10,11 D7S820 10 D8S1179 10,14 D13S317 8,12 D16S539 11,13 D18S51 10,14 D19S433 15 D21S11 28,29 FGA 20,22 PentaD 9 PentaE 5,11 TH01 9,9.3 TPOX 8 vWA 16,20 D6S1043 19 D12S391 15,21 D2S441 11,14 -
STR鉴定图
-
参考文献
-
In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: A therapy for intrauterine adhesions(2021/10/22)
作者:Liaobing Xin, Cheng Wei, Xiaomei Tong
期刊:Bioactive Materials
DOI:10.1016/j.bioactmat.2021.10.025
影响因子 :16.874
-
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma(2022/02/15)
作者:Xiaojuan Liu, Hui Ma, Lisha Ma
期刊:Bioengineered
DOI:10.1080/21655979.2022.2036912
影响因子 :6.8320
-
Pan-cancer multi-omics analyses reveal crosstalk between the Hippo and immune signaling pathways in the tumor microenvironment(2021/12/27)
作者:Chengyu Wang, Tong Zhu, Zhangxiang Zhao
期刊:Febs Letters
影响因子 :3.8640
-
miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway(2019/5/23)
作者:Ling Liu, Jianguo Hu, Tinghe Yu
期刊:Acta Biochimica Et Biophysica Sinica
影响因子 :3.5110
引用产品:CL-0197
-
Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy(2022/08/17)
作者:Dingde Long, Yayu Chen, Liangchao Qu
期刊:Oncology Letters
影响因子 :3.1110
-
Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway(2022/09/14)
作者:Jia Li, Zhidong Zhang, Yuanjing Hu
期刊:ANTI-CANCER DRUGS
DOI:10.1097/CAD.0000000000001377
影响因子 :2.3890